Inventiva SA
IVA5.650USD
+0.230+4.24%
終値 09/19, 16:00（ET）15分遅れの株価
0.00時価総額
--直近12ヶ月PER
詳細情報 Inventiva SA 企業名
Inventiva SA is a France-based company engaged in the biotechnology sector. The Company focuses on the development of therapies in the area of oncology, fibrosis and rare diseases. The Company’s pipeline comprises a number of development programs, such as Clinical Pipeline, Preclinical Pipeline, AbbVie Collaboration and Boehringer-Ingelheim collaboration. Its drug candidates target at the treatment of non-alcoholic steatohepatitis (NASH), systemic sclerosis (SSc), various types of mucopolysaccharidosis (MPS), multiple myeloma, auto-immune disorders, as well as lung cancer, among others. In addition, the Company offers drug discovery services, ranging from target identification to preclinical nomination, in numerous areas, such as silico modelling, biology, screening, absorption, distribution, metabolism and excretion (ADME), pharmacology and histology.
企業情報
企業コードIVA
会社名Inventiva SA
上場日Feb 15, 2017
最高経営責任者「CEO」Mr. Frederic Cren
従業員数- -
証券種類Ordinary Share
決算期末- -
本社所在地50 rue de Dijon
都市DAIX
証券取引所Euronext Paris
国France
郵便番号21121
電話番号33380447500
ウェブサイトhttps://inventivapharma.com/
企業コードIVA
上場日Feb 15, 2017
最高経営責任者「CEO」Mr. Frederic Cren
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Heinz Maeusli
Mr. Heinz Maeusli
Independent Director
Independent Director
--
--
Dr. Mark Pruzanski, M.D.
Dr. Mark Pruzanski, M.D.
Chairman of the Board
Chairman of the Board
--
--
Ms. Nathalie Harroy
Ms. Nathalie Harroy
Director - Human Resources
Director - Human Resources
--
--
Mr. Frederic Cren
Mr. Frederic Cren
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
--
--
Mr. Jean Volatier
Mr. Jean Volatier
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Martine Zimmerman
Ms. Martine Zimmerman
Independent Director
Independent Director
--
--
Dr. Srinivas (Srini) Akkaraju, M.D., Ph.D.
Dr. Srinivas (Srini) Akkaraju, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Annick Schwebig, M.D.
Dr. Annick Schwebig, M.D.
Independent Director
Independent Director
--
--
Andre Turenne
Andre Turenne
Independent Director
Independent Director
--
--
Dr. Jason Campagna, M.D., Ph.D.
Dr. Jason Campagna, M.D., Ph.D.
President - Research and Development, Chief Medical Officer
President - Research and Development, Chief Medical Officer
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Heinz Maeusli
Mr. Heinz Maeusli
Independent Director
Independent Director
--
--
Dr. Mark Pruzanski, M.D.
Dr. Mark Pruzanski, M.D.
Chairman of the Board
Chairman of the Board
--
--
Ms. Nathalie Harroy
Ms. Nathalie Harroy
Director - Human Resources
Director - Human Resources
--
--
Mr. Frederic Cren
Mr. Frederic Cren
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
--
--
Mr. Jean Volatier
Mr. Jean Volatier
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Martine Zimmerman
Ms. Martine Zimmerman
Independent Director
Independent Director
--
--
収益内訳
データなし
データなし
事業別
地域別
データなし
株主
更新時刻: Fri, Aug 15
更新時刻: Fri, Aug 15
株主統計
種類
株主統計
株主統計
比率
Yiheng Capital Management, L.P.
2.76%
New Enterprise Associates (NEA)
1.53%
BVF Partners L.P.
0.72%
Commonwealth Financial Network
0.06%
UBS Financial Services, Inc.
0.03%
他の
94.90%
株主統計
株主統計
比率
Yiheng Capital Management, L.P.
2.76%
New Enterprise Associates (NEA)
1.53%
BVF Partners L.P.
0.72%
Commonwealth Financial Network
0.06%
UBS Financial Services, Inc.
0.03%
他の
94.90%
種類
株主統計
比率
Investment Advisor
2.87%
Venture Capital
1.53%
Hedge Fund
0.74%
Investment Advisor/Hedge Fund
0.02%
他の
94.85%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
19
4.87M
5.09%
-661.07K
2025Q1
21
4.87M
5.09%
-959.14K
2024Q4
21
5.45M
6.26%
-698.93K
2024Q3
20
4.86M
9.25%
-1.29M
2024Q2
21
4.85M
9.24%
-1.47M
2024Q1
22
4.85M
9.31%
-1.45M
2023Q4
19
4.86M
9.33%
-1.43M
2023Q3
22
4.86M
11.53%
-1.45M
2023Q2
24
4.83M
11.47%
-1.47M
2023Q1
26
5.13M
12.18%
-904.48K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Yiheng Capital Management, L.P.
2.64M
2.76%
--
--
Mar 31, 2025
New Enterprise Associates (NEA)
1.46M
1.53%
--
--
Mar 31, 2025
BVF Partners L.P.
686.04K
0.72%
--
--
May 07, 2025
Commonwealth Financial Network
54.49K
0.06%
+12.49K
+29.73%
Mar 31, 2025
UBS Financial Services, Inc.
708.00
0%
-608.54K
-99.88%
Mar 31, 2025
Wealth Enhancement Advisory Services, LLC
10.71K
0.01%
+10.71K
--
Mar 31, 2025
Geode Capital Management, L.L.C.
4.70K
0%
--
--
May 31, 2025
Morgan Stanley & Co. International Plc
--
0%
-1.40K
-100.00%
Dec 31, 2024
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
